NECTIN3 and lung carcinoma: Other nectin-like molecules have also demonstrated clinical importance in lung cancer, such as CD112 and CD113, but CD155 raises as the most representative due to its higher affinity for TIGIT, which increases its importance as a potential target of therapeutic inhibition [20].